FDA Warning
High Lidocaine Concentration in Topical Pain Relief Products Draws Ire of FDA
The agency issued warning letters to six companies for marketing products in violation of federal law.
APRIL 17, 2024
FDA Warns of Serious Risks, Including Death, With JAK Inhibitors
The FDA is requiring the addition of warnings about increased risks for cancer, serious cardiovascular events and ...
SEPTEMBER 28, 2021
FDA Warns of Arrhythmia Risk With Lamotrigine
An FDA review of in vitro study findings found a potentially increased risk for heart arrhythmias in patients with ...
APRIL 8, 2021
FDA Warns Website Operators Illegally Selling Opioids to Consumers
The FDA has issued warning letters to 17 website operators for selling unapproved and misbranded opioids online in ...
SEPTEMBER 14, 2020
FDA Strengthens Warning on Combining Benzos and Opioids
The FDA expanded its warnings against using opioids and benzodiazepines concomitantly.
MAY 4, 2018
Use of Fentanyl Patches in Nursing Homes Persists After FDA Warning
Despite FDA warnings regarding the risk for adverse effects from administering long-acting opioids to patients who ...
JUNE 28, 2017
FDA Confirms Elevated Levels of Belladonna in Homeopathic Teething Products
The FDA found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, ...
FEBRUARY 13, 2017